Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Patterns of hepatitis B reactivation and liver test abnormalities in patients with chronic lymphocytic leukemia (CLL) treated with idelalisib plus an anti-CD20 antibody.
Journal of Clinical Oncology (2016)
  • Andrew David Zelenetz, Memorial Sloan Kettering Cancer Center
  • Anthony R. Mato, Hospital of the University of Pennsylvania
  • Tadeusz Robak, Medical University of Łódź
  • Jeffrey Alan Jones, Ohio State University
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Jacqueline Claudia Barrientos, Hofstra University
  • Jennifer R. Brown, Harvard University
  • Marco Montillo, Niguarda Ca' Granda Hospital, Milan, Italy;
  • Thomas J. Kipps, University of California, San Diego
  • Ronald Dubowy, Gilead Sciences, Inc., Foster City, CA;
  • Guan Xing, Gilead Sciences, Inc., Foster City, CA;
  • Julia Li, Gilead Sciences, Inc., Foster City, CA;
  • Peter Hillmen, St James's University Hospital
Link
Disciplines
Publication Date
May 20, 2016
DOI
10.1200/jco.2016.34.15_suppl.7533
Citation Information
Andrew David Zelenetz, Anthony R. Mato, Tadeusz Robak, Jeffrey Alan Jones, et al.. "Patterns of hepatitis B reactivation and liver test abnormalities in patients with chronic lymphocytic leukemia (CLL) treated with idelalisib plus an anti-CD20 antibody." Journal of Clinical Oncology Vol. 34 (2016) p. 7533 - 7533
Available at: http://works.bepress.com/john-pagel/309/